Enhancement of the GH responsiveness to GH releasing stimuli by lysine vasopressin in type 1 diabetic subjects

Clinical Endocrinology

Volumn 51, Issue 4, 1999, Pages 487-495

  Coiro, V ^a,d   Volpi, R ^a   Capretti, L ^b   Speroni, G ^b   Caffarri, G ^c   Marchesi, C ^a   Chiodera, P ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Hospital of Codogno   (Italy)

^c Hospital of Guastalla   (Italy)

^d Istituto di Clinica Medica Generale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CLONIDINE; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LYPRESSIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE ACTION; HORMONE RESPONSE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; VASOPRESSIN RELEASE;

ADULT; ANALYSIS OF VARIANCE; ARGININE; CASE-CONTROL STUDIES; CLONIDINE; DIABETES MELLITUS, TYPE 1; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; LYSINE VASOPRESSIN; MALE; SOMATOSTATIN; STATISTICS, NONPARAMETRIC;

EID: 0032741115     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00832.x     Document Type: Article

References (30)

1. Alba-Rota, J., Muller, O.A., Schopohl, J. & Von Werder, K. (1988) Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. Journal of Clinical Endocrinology and Metabolism, 67, 1186-1189.
2. Brostoff, J., James, V.H.T. & Landon, J. (1968) Plasma corticosterone and growth hormone response to lysine-vasopressin in man. Journal of Clinical Endocrinology and Metabolism, 28, 511-518.
3. Cavagnini, F., Raggi, U., Micossi, P., Landro, A. & Invitti, C. (1976) Effect of antiserotoninergic drug metergoline on the ACTH and cortisol response to insulin hypoglycemia and lysine vasopressin in man. Journal of Clinical Endocrinology and Metabolism, 43, 306-312.
4. Cella, S.G., Locatelli, V., De Gennaro, V., Wehrenberg, W.B. & Muller, E.E. (1987) Pharmacological manipulations of α-adrenoreceptors in the infant rat and effects on growth hormone secretion. Study of the underlying mechanisms of action. Endocrinology, 120, 1639-1643.
5. Chiodera, P. & Coiro, V. (1985) Inhibition by somatostatin of the release of growth hormone induced by lysine-vasopressin in normal subjects. Biomedicine & Pharmacotherapy, 39, 334-337.
6. Chiodera, P., Volpi, R., Cigarini, C., Caiazza, A., Marchesi, C., Rossi, G., Camellini, L., Guerra, M. & Coiro, V. (1987) Lysine-vasopressin does not affect basal and LH-RH-stimulated LH and FSH release during the menstrual cycle of normal women. Gynecological and Obstetrical Investigation, 24, 56-61.
7. Chiodera, P., Gnudi, A., Marchesi, C., Rossi, G., Camellini, L., Caiazza, A., Bianconi, L., Volpi, R. & Coiro, V. (1988) Effect of lysine vasopressin on basal and TRH stimulated TSH and PRL release in normal men. Journal of Endocrinological Investigation, 11, 497-500.
8. Chiodera, P., Volpi, R., Capretti, L., Speroni, G., Caffarri, G., Caiazza, A. & Coiro, V. (1995) Influence of residual C-peptide secretion on the arginine-vasopressin response to hypoglycemia and metoclopramide in insulin-dependent diabetes. European Journal of Clinical Investigation, 25, 568-573.
9. Chiodera, P., Volpi, R., Capretti, L., Speroni, G., Necchi-Ghiri, S., Caffarri, G., Colla, R. & Coiro, V. (1997) Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. Clinical Endocrinology, 46, 351-357.
10. Coiro, V., Volpi, R., Muzzetto, P., Caiazza, A., Petrolini, R., Cerri, L., Roberti, G. & Chiodera, P. (1985) Cholinergic muscarinic receptors participate in growth hormone secretion induced by lysine-vasopressin. Hormone and Metabolic Research, 6, 316-317.
11. Coiro, V., Passeri, M., Gardini, E., Capretti, L., Speroni, G., Davoli, C., Maffei, M.L., Fagnoni, F., Bianconi, L., Volpi, R. & Chiodera, P. (1990) Reduced sensitivity to pirenzepine-induced blockade of growth hormone responses to arginine, exercise, and growth hormone-releasing hormone in type I diabetic subjects. Metabolism, 39, 668-675.
12. Coiro, V., Volpi, R., Capretti, L., Colla, R., Caffarri, G., Vescovi, P.P. & Chiodera, P. (1995) Dopaminergic and cholinergic control of arginine-vasopressin secretion in type I diabetic men. European Journal of Clinical Investigation, 25, 412-417.
13. Culpepper, R.M., Hebert, S.C. & Andreoli, T.E. (1985) The posterior pituitary and water metabolism. In Williams Textbook of Endocrinology (eds. J. D. Wilson & D. W. Foster), pp 614-652. Saunders Company, Philadelphia.
14. del Pozo, E., Kleinstem, J., Brun del Re, R., Derrer, F. & Martin-Perez, J. (1980) Failure of oxytocin and lysine-vasopressin to stimulate prolactin release in humans. Hormone and Metabolic Research, 12, 26-28.
15. Fisher, B.M., Baylis, P.M., Thornton, S. & Frier, B.M. (1989) Arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in type I (insulin-dependent) diabetes. Journal of Clinical Endocrinology and Metabolism, 68, 688-692.
16. Gillies, G., Limon, E.A. & Lowry, P.J. (1982) Corticotropin-releasing activity of the new CRF is potentiated several times by vasopressin. Nature, 299, 355-357.
17. Giustina, A. & Wehrenberg, W.P. (1994) Growth hormone neuro-regulation in diabetes mellitus. Trends in Endocrinology and Metabolism, 5, 73-78.
18. Gwinup, G., Steinberg, T., King, C.G. & Vernikos-Danellis, J. (1967) Vasopressin-induced ACTH secretion in man. Journal of Clinical Endocrinology and Metabolism, 27, 927-930.
19. Houben, H. & Denef, C. (1994) Bioactive peptides in anterior pituitary cells. Peptides, 15, 547-582.
20. Kabayama, Y., Kato, Y., Murakami, Y., Tanaka, H. & Imura, H. (1986) Stimulation by alpha-adrenergic mechanisms of the secretion of growth hormone-releasing factor (GRF) from perfused rat hypothalamus. Endocrinology, 119, 432-434.
21. Legros, J.J., Chiodera, P. & Demey-Ponsart, E. (1982) Inhibitory influence of exogenous oxytocin on adrenocorticotropin secretion in normal human subjects. Journal of Clinical Endocrinology and Metabolism, 55, 1035-1039.
22. Milles, J.J., Baylis, P.H. & Wright, A.D. (1980) Plasma vasopressin during insulin withdrawal in insulin-dependent diabetes. Diabetologia, 20, 607-611.
23. Press, M., Caprio, S., Tamborlane, W.V., Bhushan, R., Thorner, M., Vale, W., River, J. & Sherwin, R.S. (1992) Pituitary response to growth hormone releasing hormone in IDDM: abnormal responses to stimuli and hypoglycemia. Diabetes, 41, 17-21.
24. Richardson, S.B., Holander, C.S., D'Eletto, R., Greenleag, P.W. & Thaw, O.C. (1980) Acetylcholine inhibits the release of somatostatin from rat hypothalamus in vitro. Endocrinology, 107, 122-129.
25. Schally, A.V., Steelman, S.L. & Bowers, C.Y. (1965) Effect of hypothalamic extract on release of growth hormone in vitro. Proceedings of the Society for Experimental Biology and Medicine, 119, 208-212.
26. Spoudeas, H.A., Winrow, A.P., Hindmarh, P.C. & Brook, C.G.D. (1994) Low-dose growth hormone-releasing hormone tests: a dose-response study. European Journal of Endocrinology, 131, 238-245.
27. 27], GH-RH (1-29)-NH2, on growth hormone secretion in normal men: dose-response relationship. Clinical Pharmacology and Therapeutics, 40, 627-633.
28. Wurzburger, M.S., Prevezevic, G.M., Sonken, P.H., Peric, L.A., Till, S. & Morris, R.W. (1990a) The effects of imposed blood glucose on growth hormone and cortisol secretion in insulin-dependent diabetes mellitus. Clinical Endocrinology, 32, 787-797.
29. Wurzburger, M.S., Prevezevic, G.M., Sonken, P.H., Peric, L.A., Till, S. & Morris, R.W. (1990b) Effect of imposed blood glucose on insulin-induced hypoglycemia, TRH, GH-RH and exercise tests in insulin-dependent diabetes. Clinical Endocrinology, 32, 799-807.
30. Zerbe, R.L., Vinicor, F. & Robertson, G.L. (1985) Regulation of plasma vasopressin in insulin-dependent diabetes mellitus. American Journal of Physiology, 12, E317-E325.